Daunorubicin

Daunorubicin is an antineoplastic agent used for the treatment of acute leukemias. Daunorubicin belongs to the group of anthracycline antibiotics and inhibits the growth and division of cancer cells by interfering with DNA and RNA synthesis. It is used in chemotherapy regimens for treating acute myeloid and lymphoblastic leukemias in adults and children. The drug is administered intravenously under medical supervision, with possible side effects including bone marrow suppression, nausea, and cardiotoxicity.

Wikipedia page List of medicines with this active substance